%0 Journal Article
%T The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management
%A Guibin Qiao
%A Qihang Zhu
%A Yong Tang
%A Zhe He
%J SCIE-indexed Journal
%D 2014
%R 10.3978/j.issn.2072-1439.2014.09.15
%X In the past few decades, the incidence of lung adenocarcinoma has been increasing rapidly worldwide. Adenocarcinoma has become the most common histological type of lung cancer, and approximately a half of lung cancer patients are diagnosed with adenocarcinoma type at present (1). Meanwhile, a great progress in oncology, surgery, radiology, and molecular biology has significantly improved the understanding of lung adenocarcinoma (2-9). Therefore, the 2004 WHO lung adenocarcinoma classification cannot perfectly guide current clinical practice
%U http://jtd.amegroups.com/article/view/3059/html